Vir Biotechnology Inc. (NASDAQ: VIR) reported Q1 EPS of ($0.48), $0.57 better than the analyst estimate of ($1.05). Revenue for the quarter came in at $56.38 million versus the consensus estimate of $11.99 million.

For earnings history and earnings-related data on Vir Biotechnology Inc. (VIR) click here.